Medicinova
Clinical trials sponsored by Medicinova, explained in plain language.
-
Could an old asthma drug slow ALS? new trial aims to find out
Disease control OngoingThis clinical trial tests whether ibudilast (MN-166), a drug previously used for asthma, can slow the progression of amyotrophic lateral sclerosis (ALS). The study involves 234 adults with ALS, who will receive either ibudilast or a placebo for 12 months, followed by a 6-month op…
Phase: PHASE2, PHASE3 • Sponsor: MediciNova • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New pill aims to tackle fatty liver and diabetes at once
Disease control OngoingThis phase 2 trial tests an oral drug called MN-001 (tipelukast) in 40 adults with non-alcoholic fatty liver disease, type 2 diabetes, and high triglycerides. Participants take either the drug or a placebo daily for 24 weeks. The study measures changes in liver fat and blood fat …
Phase: PHASE2 • Sponsor: MediciNova • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC